Yoshimi Kaise

Statistics

Publications

Citations

133

H-Index

Active since

2017

Affiliations

Chiba University(Current)

The University of Tokyo

Jikei University School of Medicine

Sanno Medical Center

SHOWA Medical University

Yoshimi Kaise is an author at Chiba University specializing in hepatocellular carcinoma pathogenesis, cancer pharmacology, and hepatocellular carcinoma pharmacotherapy.

Publications per year

2017–2019

Publications

miR-425 regulates inflammatory cytokine production in CD4+ T cells via N-Ras upregulation in primary biliary cholangitis

Ryo Nakagawa, Ryosuke Muroyama, Chisato Saeki et al. · Journal of Hepatology · 2017 · 52 citations

Life Sciences, Cell Biology, Immunology +17

Predominance of regorafenib over sorafenib: Restoration of membrane‐bound MICA in hepatocellular carcinoma cells

Jun Arai, Kaku Goto, Anthony Stephanou et al. · Journal of Gastroenterology and Hepatology · 2017 · 35 citations

Medicine, Oncology, Pharmacology +17

Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells

Jun Arai, Kaku Goto, Yasushi Tanoue et al. · International Journal of Cancer · 2018 · 35 citations · Full text

Medicine, Molecular Biology, Oncology +14

CD4<sup>+</sup> T cells from patients with primary biliary cholangitis show T cell activation and differentially expressed T‐cell receptor repertoires

Ryo Nakagawa, Ryosuke Muroyama, Chisato Saeki et al. · Hepatology Research · 2019 · 11 citations

Life Sciences, Immunology, Pathology +17

1–4 of 4